Arcellx (ACLX) Profit After Tax (2021 - 2025)
Arcellx's (ACLX) quarterly Profit After Tax came in at -$58.0 million in Q4 2025, down 23.14% year-on-year from -$75.4 million in Q4 2024, and down 4.5% quarter-over-quarter from -$55.5 million in Q3 2025.
Arcellx (ACLX) Profit After Tax (2021 - 2025) Analysis & Trends
Arcellx's Profit After Tax history runs 5 years deep, the most recent figure standing at -$58.0 million for Q4 2025.
- On a quarterly basis, Profit After Tax fell 23.14% year-over-year to -$58.0 million in Q4 2025; TTM through Dec 2025 was -$228.5 million, a 112.85% decrease from a year earlier, with the FY2025 full-year figure at -$228.9 million, down 113.27% from the prior year.
- Profit After Tax fell to -$58.0 million in Q4 2025 per ACLX's latest filing, from -$55.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at $19.8 million in Q4 2023 and bottomed at -$92.9 million in Q3 2022.
- The 5-year median for Profit After Tax is -$27.3 million (2023), against an average of -$33.0 million.
- Across the five-year window, Profit After Tax soared 151.13% in 2023 and tumbled 765.1% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$20.7 million in 2021, then plunged by 87.78% to -$38.8 million in 2022, then soared by 151.13% to $19.8 million in 2023, then sank by 337.26% to -$47.1 million in 2024, then slipped by 23.14% to -$58.0 million in 2025.
- Per Business Quant, the three latest ACLX Profit After Tax figures stand at -$58.0 million (Q4 2025), -$55.5 million (Q3 2025), and -$52.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -57.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.98 Mn |
| Sep 30, 2025 | -55.48 Mn |
| Jun 30, 2025 | -52.77 Mn |
| Mar 31, 2025 | -62.27 Mn |
| Dec 31, 2024 | -47.08 Mn |
| Sep 30, 2024 | -25.87 Mn |
| Jun 30, 2024 | -27.20 Mn |
| Mar 31, 2024 | -7.20 Mn |
| Dec 31, 2023 | 19.84 Mn |
| Sep 30, 2023 | -39.34 Mn |
| Jun 30, 2023 | -23.85 Mn |
| Mar 31, 2023 | -27.34 Mn |
| Dec 31, 2022 | -38.81 Mn |
| Sep 30, 2022 | -92.87 Mn |
| Jun 30, 2022 | -30.77 Mn |
| Mar 31, 2022 | -26.04 Mn |
| Dec 31, 2021 | -20.67 Mn |
| Sep 30, 2021 | -17.09 Mn |
| Jun 30, 2021 | -15.93 Mn |
| Mar 31, 2021 | -11.28 Mn |